Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mart Microbiology is a Dutch medical technology company specializing in the development of automated systems for microbiology laboratories. The company's core product, the Anoxomat, is a highly regarded system used to create precise anaerobic, microaerophilic, and capnophilic environments for the cultivation of bacteria. This technology is essential for clinical laboratories identifying pathogens responsible for infectious diseases, as well as for food and pharmaceutical quality control. By replacing manual methods like gas jars and anaerobic chambers, Mart Microbiology's solutions improve laboratory workflow and result reproducibility. In 2016, the company was acquired by Advanced Instruments, a leading provider of analytical instruments for the clinical and biopharmaceutical markets. Today, Mart Microbiology's technology continues to be a standard in the field of anaerobic microbiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mart Microbiology.